Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 2
1980 1
1981 1
1982 2
1984 4
1985 4
1986 3
1987 1
1988 1
1989 6
1992 2
1993 3
1995 2
1996 3
1997 1
1998 5
1999 3
2000 1
2001 5
2002 6
2003 11
2004 7
2005 4
2006 3
2007 3
2008 3
2009 3
2010 7
2011 6
2012 5
2013 5
2014 3
2015 7
2016 10
2017 7
2018 6
2019 8
2020 11
2021 15
2022 8
2023 4
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Results by year

Filters applied: . Clear all
Page 1
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
Sadoff J, Gray G, Vandebosch A, Cárdenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Fennema H, Spiessens B, Offergeld K, Scheper G, Taylor KL, Robb ML, Treanor J, Barouch DH, Stoddard J, Ryser MF, Marovich MA, Neuzil KM, Corey L, Cauwenberghs N, Tanner T, Hardt K, Ruiz-Guiñazú J, Le Gars M, Schuitemaker H, Van Hoof J, Struyf F, Douoguih M; ENSEMBLE Study Group. Sadoff J, et al. Among authors: van hoof j. N Engl J Med. 2021 Jun 10;384(23):2187-2201. doi: 10.1056/NEJMoa2101544. Epub 2021 Apr 21. N Engl J Med. 2021. PMID: 33882225 Free PMC article. Clinical Trial.
Creating Age-Friendly Communities: Housing and Technology.
van Hoof J, Marston HR, Brittain KR, Barrie HR. van Hoof J, et al. Healthcare (Basel). 2019 Nov 3;7(4):130. doi: 10.3390/healthcare7040130. Healthcare (Basel). 2019. PMID: 31684164 Free PMC article.
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
Sadoff J, Gray G, Vandebosch A, Cárdenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Van Dromme I, Spiessens B, Vingerhoets J, Custers J, Scheper G, Robb ML, Treanor J, Ryser MF, Barouch DH, Swann E, Marovich MA, Neuzil KM, Corey L, Stoddard J, Hardt K, Ruiz-Guiñazú J, Le Gars M, Schuitemaker H, Van Hoof J, Struyf F, Douoguih M; ENSEMBLE Study Group. Sadoff J, et al. Among authors: van hoof j. N Engl J Med. 2022 Mar 3;386(9):847-860. doi: 10.1056/NEJMoa2117608. Epub 2022 Feb 9. N Engl J Med. 2022. PMID: 35139271 Free PMC article. Clinical Trial.
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.
Stephenson KE, Le Gars M, Sadoff J, de Groot AM, Heerwegh D, Truyers C, Atyeo C, Loos C, Chandrashekar A, McMahan K, Tostanoski LH, Yu J, Gebre MS, Jacob-Dolan C, Li Z, Patel S, Peter L, Liu J, Borducchi EN, Nkolola JP, Souza M, Tan CS, Zash R, Julg B, Nathavitharana RR, Shapiro RL, Azim AA, Alonso CD, Jaegle K, Ansel JL, Kanjilal DG, Guiney CJ, Bradshaw C, Tyler A, Makoni T, Yanosick KE, Seaman MS, Lauffenburger DA, Alter G, Struyf F, Douoguih M, Van Hoof J, Schuitemaker H, Barouch DH. Stephenson KE, et al. Among authors: van hoof j. JAMA. 2021 Apr 20;325(15):1535-1544. doi: 10.1001/jama.2021.3645. JAMA. 2021. PMID: 33704352 Free PMC article. Clinical Trial.
Methods proposed for monitoring the implementation of evidence-based research: a cross-sectional study.
Puljak L, Bala MM, Zając J, Meštrović T, Buttigieg S, Yanakoulia M, Briel M, Lunny C, Lesniak W, Poklepović Peričić T, Alonso-Coello P, Clarke M, Djulbegovic B, Gartlehner G, Giannakou K, Glenny AM, Glenton C, Guyatt G, Hemkens LG, Ioannidis JPA, Jaeschke R, Juhl Jørgensen K, Martins-Pfeifer CC, Marušić A, Mbuagbaw L, Meneses Echavez JF, Moher D, Nussbaumer-Streit B, Page MJ, Pérez-Gaxiola G, Robinson KA, Salanti G, Saldanha IJ, Savović J, Thomas J, Tricco AC, Tugwell P, van Hoof J, Pieper D. Puljak L, et al. Among authors: van hoof j. J Clin Epidemiol. 2024 Apr;168:111247. doi: 10.1016/j.jclinepi.2024.111247. Epub 2024 Jan 5. J Clin Epidemiol. 2024. PMID: 38185190
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
Hardt K, Vandebosch A, Sadoff J, Le Gars M, Truyers C, Lowson D, Van Dromme I, Vingerhoets J, Kamphuis T, Scheper G, Ruiz-Guiñazú J, Faust SN, Spinner CD, Schuitemaker H, Van Hoof J, Douoguih M, Struyf F; ENSEMBLE2 study group. Hardt K, et al. Among authors: van hoof j. Lancet Infect Dis. 2022 Dec;22(12):1703-1715. doi: 10.1016/S1473-3099(22)00506-0. Epub 2022 Sep 13. Lancet Infect Dis. 2022. PMID: 36113538 Free PMC article. Clinical Trial.
180 results